Американское общество гирудотерапии

Medicinal leech therapy and Aeromonas spp. infection

Research article published in European Journal of Clinical Microbiology & Infectious Diseases (2016)

Последнее обновление: June 18, 2026Рецензент: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportБезопасность и инфекционный контрольVerriere B, Sabatier B, Carbonnelle E et al. · European journal of clinical microbiology & infectious diseases, 2016

Abstract

While the use of medicinal leech therapy (MLT) in reconstructive and orthopaedic surgery is widely described, post-operative complications related to leeches remain a major concern. Aeromonas spp. strains are involved in the majority of reported cases. As surgical success rate is directly impacted, an adapted antibiotic prophylaxis should be instituted in order to minimize these complications. We assessed pharmaceutical process, microbiological control and related infections in order to provide data and choose the appropriate antibiotherapy for patients requiring MLT. We report a clinical and microbiological study over a 24-month period. Clinical data were collected from patients' database, and microbiological analysis both on leeches' tank water and crushed leeches were performed to characterize isolated strains and their susceptibility to antibiotics. A total of 595 leeches were used to treat 28 patients (12 in plastic surgery and 16 in orthopaedic surgery), and three documented cases of post-operative infections were reported. Aeromonas spp. isolates yielded from 62 % of analyzed batches (75 % of Aeromonas veronii). Eighteen Aeromonas spp. isolates yielded from 23 water samples and three crushed leeches. Isolates were similar in tank and crushed leeches. Strains were susceptible to fluoroquinolones, sulfamethoxazole/trimethoprim, aminosides, and third-generation cephalosporins but resistant to amoxicillin/clavulanic acid and second-generation cephalosporins. According to collected data, routine tank water microbiological analyses are mandatory in order to identify leeches' batches containing resistant strains and to discard them. In this context, the surgeon is able to select an appropriated antibiotic prophylaxis in order to avoid MLT associated serious post-operative complications.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAeromonasAnimalsAnti-Bacterial AgentsAntibiotic ProphylaxisFemaleGram-Negative Bacterial InfectionsHumansLeechesLeechingMalePostoperative Complications

Резюме

24-month clinical and microbiological study of 595 leeches used in 28 patients across plastic and orthopedic surgery: 62% of analyzed batches yielded Aeromonas spp. isolates; recommends routine tank-water microbiological surveillance.

Почему это важно для гирудотерапии

Over 24 months, this study assessed pharmaceutical process, microbiological control (tank water and crushed leeches), and related infections in 595 leeches used to treat 28 plastic- and orthopaedic-surgery patients, reporting three documented post-operative infections. Aeromonas spp. were recovered from 62% of batches (75% Aeromonas veronii); isolates were susceptible to fluoroquinolones, sulfamethoxazole/trimethoprim, aminoglycosides, and third-generation cephalosporins but resistant to amoxicillin/clavulanic acid and second-generation cephalosporins. For ASH, this is directly relevant hirudotherapy safety and prophylaxis data, recommending routine tank water screening to identify and discard resistant batches. The abstract does not label the design; the cohort is small (28 patients, three infections), limiting incidence precision and generalizability.

Цитирование

Medicinal leech therapy and Aeromonas spp. infection.

Verriere B, Sabatier B, Carbonnelle E et al. · European journal of clinical microbiology & infectious diseases, 2016

Связанный клинический контекст

Узнайте, как это исследование связано с клинической практикой

Добавлено в библиотеку ASH: May 26, 2026 · Последнее обновление сайта: June 18, 2026

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.